David Einhorn's position in Gain Therapeutics is currently worth $2.68 Million. That's 0.17% of their equity portfolio (28th largest holding). The investor owns 4.66% of the outstanding Gain Therapeutics stock. David Einhorn acquired their 547 Thousand shares in Q1 2021. So far they never sold any shares in the company. The investor's estimated purchase price is $7.17 Million, resulting in a loss of 63%.